2023

Dr. Mark Powell is a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as a senior analytical chemist. Mark has served as both Honorary Secretary and Honorary Treasurer of the RSC’s Analytical Division and led a working group on continuing professional development until July 2016. He has worked at a senior level in a number of companies with responsibility for analytical development and equipment qualification.

In 2010 Mark was appointed Scientific Manager of a UK-based pharmaceutical CRO, with responsibility for guiding the direction of drug development programmes as well as establishing collaborations with academia and instrument manufacturers. In 2013, he set up his own company to provide training and consultancy services to the pharmaceutical industry. His consultancy work has involved, amongst other things, managing the analytical aspects of pharmaceutical development programmes and conducting data integrity audits.

He is in demand as a trainer in topics such as chromatography, spectroscopy, dissolution testing, data integrity, control of impurities, technical writing, stability/stress studies, method validation, extractables and leachables, and root cause analysis.

Theresa Jeary holds a master’s degree in Pharmaceutical Science from the Royal College of Surgeons, Ireland.

Theresa has over 30 years’ experience working in both the Pharmaceutical and Medical Device industries and has worked in a variety of roles across the full development cycle from product concept and early stage development, process transfer, validation and regulatory departments.

In addition to her product development and global regulatory expertise, Theresa has over 12 years Notified Body experience in the areas of Rule 14 devices and Article 117 NB Opinions.

Theresa is a regular presenter on combination products in the EU and she has extensive experience of interacting with EU Competent Authorities.

Dr. Niamh Mac Fhionnlaoich is a Research Fellow at APC where she promotes digital and machine learning solutions.  Her work currently focuses on solubility prediction to facilitate solvent selection and accelerate pharmaceutical process development.

She holds a PhD in Chemical Engineering from University College London and a Bachelor of Engineering in Chemical and Bioprocess Engineering from University College Dublin.

Darryl Souness is Head of Analytical at Cambrex in Edinburgh, a leading contract development and manufacturing organisation that provides drug substance, drug product, and analytical services across the entire drug lifecycle. He has over 20 years of experience in analytical chemistry, with a focus on stability and lot release testing, solid state characterisation, method development and validation. He leads a team of highly skilled scientists who use state-of-the-art equipment and techniques to provide the data needed for early-phase drug development decisions.

Darryl joined Cambrex in 2019, after working as a Head of Analytical at Solid Form Solutions, a company that was acquired by Cambrex. He entered the industry in 1992, with 4 years in Inorganics and Solvent Reclamation Chemistry. Prior to joining Cambrex, Darryl worked for over 19 years in senior analytical roles with contract research organisations.

Christopher Hartnett is the Business Development Manager at EMBALL’ISO, a global leader in the design, manufacture, and validation of passive high-performance isothermal packaging for the transport of pharmaceutical products. EMBALL’ISO is also a pioneer and expert in Preconditioning, Rental, and Reverse Logistics services for a Sustainable Cold Chain.

Christopher has Postgraduate Certificates in Business Finance and Marketing and Digital Strategy and an MSc in Business Practice from the Irish Management Institute.

Cécile Jacoby joined Q1 Scientific as General Manager in 2023 to manage our 20,000 square feet facility in Belgium. With more than 25 years of experience in senior strategic and operations roles across pharmaceutical, vaccine, healthcare and cell therapy companies, Cécile has a proven track record in developing, driving and managing business operations. After working at Director level in GSK for over 10 years, Cécile became a Senior Executive Consultant delivering several worldwide assignments to pharmaceutical, R&D and biotechnology companies. Cécile also took over the general management of a Belgian Biotech group’s subsidiary and an industrial group’s holding company.

Stephen Delaney, appointed CEO of Q1 Scientific in 2018 and subsequently becoming Managing Director in 2022, has been instrumental in driving Q1 Scientific’s success. Under his visionary leadership, Q1 Scientific achieved remarkable milestones, including winning the prestigious ‘Contract Services Company of the Year’ at the Pharma Industry Awards in 2020 and being named ‘Business of the Year’ at the Waterford Chamber Business Awards in 2021.

In 2023, Stephen led Q1 Scientific’s expansion in Waterford, transforming the facility into a state-of-the-art pharmaceutical stability storage hub spanning 30,000 square feet. Simultaneously, he oversaw the opening of a second 20,000 square feet stability storage facility in Belgium.

As Managing Director, Stephen plays a pivotal role in the pharmaceutical supply chain. His expertise ensures that temperature-controlled stability storage meets the stringent demands of the world’s largest pharmaceutical and medical device companies.

Stephen holds a degree in Materials Technology and Engineering from the University of Limerick (2010) and a Master’s degree in Business Management from Smurfit Business School.

Are you seeking stability storage solutions? Connect with Stephen Delaney and explore how Q1 Scientific can help.